Company intelligence / Profile preview
Kexing Biopharm
Jinan, Shandong, Chinakexingpharma.com ↗
- Ownership
- Private
- Employees
- ~29
- Development stage
- Phase 3
01
Overview
Kexing is a leading Chinese biopharmaceutical company with over two decades of experience in R&D and commercialization of biologics. It has multiple approved products in China and internationally—including recombinant human insulin and growth hormone—and an expanding global presence. Its recent cancer drug Apexelsin received regulatory approvals in Peru and Europe for metastatic breast/pancreatic/non-small cell lung cancer. The company continues to invest in new modalities such as animal vaccines and synthetic biology.
- Therapeutic areas
- OncologyEndocrinologyImmunologyHematologyGastroenterologyInfectious Diseases
- Modalities
- Recombinant proteinsAntibodies (including antibody-drug conjugates)Cell therapiesBiosimilarsSmall molecule drugs
- Industry
- Pharma
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Haichang Biotech—collaboration on Apexelsin albumin-bound paclitaxel drug developmentInternational distribution partners across South America/EU/Africa/Middle East/Southeast Asia/East Europe
Beyond the preview
Go deeper on Kexing Biopharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kexing Biopharm.